The renewal and differentiation of Isl1+ cardiovascular progenitors are controlled by a Wnt/β-catenin pathway

被引:254
作者
Qyang, Yibing
Martin-Puig, Silvia
Chiravuri, MUrali
Chen, Shuibing
Xu, Huansheng
Bu, Lei
Jiang, Xin
Lin, Lizhu
Granger, Anne
Moretti, Alessandra
Caron, Leslie
Wu, Xu
Clarke, Jonathan
Taketo, Makoto M.
Laugwitz, Karl-Ludwig
Moon, Randall T.
Gruber, Peter
Evans, Sylvia M.
Ding, Sheng
Chien, Kenneth R.
机构
[1] Massachusetts Gen Hosp, Cardiovasc Res Ctr, Boston, MA 02114 USA
[2] Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA
[3] Univ Calif San Diego, Skaggs Sch Pharm, La Jolla, CA 92093 USA
[4] Childrens Hosp Philadelphia, Cardiac Ctr, Philadelphia, PA 19104 USA
[5] Tech Univ Munich, Klinikum Rechts Isar, Med Klin, D-81675 Munich, Germany
[6] Kyoto Univ, Grad Sch Med, Dept Pharmacol, Kyoto 6068501, Japan
[7] Univ Washington, Sch Med, Dept Pharmacol, Seattle, WA 98109 USA
[8] Univ Washington, Sch Med, Howard Hughes Med Inst, Seattle, WA 98109 USA
[9] Univ Washington, Sch Med, Inst Stem Cell & Regenerat Med, Seattle, WA 98109 USA
[10] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA
[11] Harvard Univ, Stem Cell Inst, Cambridge, MA 02138 USA
关键词
D O I
10.1016/j.stem.2007.05.018
中图分类号
Q813 [细胞工程];
学科分类号
摘要
Isl1(+) cardiovascular progenitors and their downstream progeny play a pivotal role in cardiogenesis and lineage diversification of the heart. The mechanisms that control their renewal and differentiation are largely unknown. Herein, we show that the Wnt/beta-catenin pathway is a major component by which cardiac mesenchymal cells modulate the prespecification, renewal, and differentiation of isl1(+) cardiovascular progenitors. This microenvironment can be reconstituted by a Wnt3a-secreting feeder layer with ES cell-derived, embryonic, and postnatal isl1(+) cardiovascular progenitors. In vivo activation of beta-catenin signaling in isl1(+) progenitors of the secondary heart field leads to their massive accumulation, inhibition of differentiation, and outflow tract (OFT) morphogenic defects. In addition, the mitosis rate in OFT myocytes is significantly reduced following beta-catenin deletion in isl1(+) precursors. Agents that manipulate Wnt signals can markedly expand isl1(+) progenitors from human neonatal hearts, a key advance toward the cloning of human isl1(+) heart progenitors.
引用
收藏
页码:165 / 179
页数:15
相关论文
共 34 条
[1]   A clonogenic common myeloid progenitor that gives rise to all myeloid lineages [J].
Akashi, K ;
Traver, D ;
Miyamoto, T ;
Weissman, IL .
NATURE, 2000, 404 (6774) :193-197
[2]   Isl1 identifies a cardiac progenitor population that proliferates prior to differentiation and contributes a majority of cells to the heart [J].
Cai, CL ;
Liang, XQ ;
Shi, YQ ;
Chu, PH ;
Pfaff, SL ;
Chen, J ;
Evans, S .
DEVELOPMENTAL CELL, 2003, 5 (06) :877-889
[3]   Longevity and lineages: Toward the integrative biology of degenerative diseases in heart, muscle, and bone [J].
Chien, KR ;
Karsenty, G .
CELL, 2005, 120 (04) :533-544
[4]  
DasGupta R, 1999, DEVELOPMENT, V126, P4557
[5]  
Ding S, 2003, P NATL ACAD SCI USA, V100, P7632, DOI 10.1073/pnas.0732087100
[6]   Mef2c is a direct transcriptional target of ISL1 and GATA factors in the anterior heart field during mouse embryonic development [J].
Dodou, E ;
Verzi, MP ;
Anderson, JR ;
Xu, SM ;
Black, BL .
DEVELOPMENT, 2004, 131 (16) :3931-3942
[7]   Missing links in GSK3 regulation [J].
Dominguez, I ;
Green, JBA .
DEVELOPMENTAL BIOLOGY, 2001, 235 (02) :303-313
[8]   Intestinal polyposis in mice with a dominant stable mutation of the β-catenin gene [J].
Harada, N ;
Tamai, Y ;
Ishikawa, T ;
Sauer, B ;
Takaku, K ;
Oshima, M ;
Taketo, MM .
EMBO JOURNAL, 1999, 18 (21) :5931-5942
[9]   Multipotent Flk-1+ cardiovascular progenitor cells give rise to the cardiomyocyte, endothelial, and vascular smooth muscle lineages [J].
Kattman, Steven J. ;
Huber, Tara L. ;
Keller, Gordon M. .
DEVELOPMENTAL CELL, 2006, 11 (05) :723-732
[10]   1-azakenpaullone is a selective inhibitor of glycogen synthase kinase-3β [J].
Kunick, C ;
Lauenroth, K ;
Leost, M ;
Meijer, L ;
Lemcke, T .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2004, 14 (02) :413-416